drugset / Trial / NCT02581696
The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers
Phase 1
Completed
24 enrolled
Boryung Pharmaceutical Co., Ltd
The Catholic University of Korea · collab
NaSingle-groupOpen-labelOther
Summary
An open-label, multiple-dose, single-arm, phase 1 study to evaluate the drug-drug interaction and safety of Lafutidine and Irsogladine maleate in healthy adult volunteers
Timeline
- Start
- 2015-08
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irsogladine | Small molecule | 2 mg | — |
| Subject | Lafutidine | Small molecule | 10 mg | — |